Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Sudden-onset severe presyncope in a 67-year-old man.

Sanders KH, Martin CA, Virdee M.

Heart. 2019 Apr;105(8):657-659. doi: 10.1136/heartjnl-2018-314118. Epub 2018 Dec 4.

PMID:
30514728
2.

In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptors.

Eltze M, Boer R, Michel MC, Hein P, Testa R, Ulrich WR, Kolassa N, Sanders KH.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Jun;363(6):649-62.

PMID:
11414660
3.

Rhodamine 123 efflux modulation in the presence of low or high serum from CD56+ hematopoietic cells or CD34+ leukemic blasts by B9309-068, a newly designed pyridine derivative.

Beck JF, Buchholz F, Ulrich WR, Boer R, Sanders KH, Niethammer D, Gekeler V.

Cancer Lett. 1998 Jul 17;129(2):157-63.

PMID:
9719457
4.

Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.

Gekeler V, Boer R, Uberall F, Ise W, Schubert C, Utz I, Hofmann J, Sanders KH, Sch├Ąchtele C, Klemm K, Grunicke H.

Br J Cancer. 1996 Sep;74(6):897-905.

5.

The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance.

Gekeler V, Ise W, Sanders KH, Ulrich WR, Beck J.

Biochem Biophys Res Commun. 1995 Mar 8;208(1):345-52.

PMID:
7887949
6.

The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance.

Gekeler V, Boer R, Ise W, Sanders KH, Sch├Ąchtele C, Beck J.

Biochem Biophys Res Commun. 1995 Jan 5;206(1):119-26.

PMID:
7818510
7.
8.
9.

Is blockade of alpha 1-adrenoceptors favourable in hypotension induced by stimulation of serotonin1A receptors in conscious dogs?

Beller KD, Boer R, Sanders KH, Walter B.

Drugs. 1990;40 Suppl 4:38-41. No abstract available.

PMID:
1982653
10.

Central and peripheral hypotensive activity of urapidil and its M1 and M2 metabolites in the cat.

Boss H, Boer R, Beller KD, Sanders KH.

Drugs. 1990;40 Suppl 4:34-7. No abstract available.

PMID:
1982652
11.

Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists.

Eltze M, Boer R, Sanders KH, Boss H, Ulrich WR, Flockerzi D.

Chirality. 1990;2(4):233-40.

PMID:
1964575
12.

Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.

Sanders KH, Beller KD, Kolassa N.

J Cardiovasc Pharmacol. 1990;15 Suppl 7:S86-93.

PMID:
1702492
13.

Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.

Kolassa N, Beller KD, Sanders KH.

Am J Cardiol. 1989 Aug 15;64(7):7D-10D. Review.

PMID:
2569265
14.

Evidence for the interaction of urapidil with 5-HT1A receptors in the brain leading to a decrease in blood pressure.

Kolassa N, Beller KD, Sanders KH.

Am J Cardiol. 1989 Feb 2;63(6):36C-39C. Review.

PMID:
2643854
15.
16.

Mechanoreceptors in rat glabrous skin: redevelopment of function after nerve crush.

Sanders KH, Zimmermann M.

J Neurophysiol. 1986 Apr;55(4):644-59.

PMID:
3701398
17.

Influence of urapidil on alpha- and beta-adrenoreceptors in pithed rats.

Sanders KH, Kilian U, Kolassa N, Schoetensack W.

J Auton Pharmacol. 1985 Dec;5(4):307-16.

PMID:
3005330
19.

Biotransformation of urapidil: metabolites in serum and urine and their biological activity in vitro and in vivo.

Zech K, Eltze M, Kilian U, Sanders KH, Kolassa N.

Arch Int Pharmacodyn Ther. 1984 Dec;272(2):180-96.

PMID:
6098228
20.

Supplemental Content

Loading ...
Support Center